Mototsugu Shimokawa

16PUBLICATIONS
94CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 28, 2026
Nuclear Pan-Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma.

|Jul 22, 2026
Perioperative Aspirin Continuation in Patients Requiring Secondary Prevention Undergoing Anatomical Lung Resection: A Propensity Score-Weighted Analysis.

|Feb 03, 2026
Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine.

Ayako Higuchi, Yumiko Koi, Tomoaki Eto

|Nov 17, 2025
Prognostic factors for malignant tumors arising from mature cystic teratomas: a study involving the Kansai Clinical Oncology Group (KCOG-G1305s study).

Fuminori Ito, Mototsugu Shimokawa, Atsushi Sugiura

|May 15, 2025
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma.

Makoto Yoshimitsu, Ilseung Choi, Shigeru Kusumoto

|Apr 15, 2024
Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.

Ayako Nakashoji, Naoki Haratake, Atrayee Bhattacharya

Pageof 3

Frequent Collaborators

3 joint publications

Shinkichi Takamori

3 joint publications

Kazuki Takada

2 joint publications

Fumihiko Kinoshita

2 joint publications

Takashi Motohashi